Regentatlantic Capital LLC Novartis Ag Transaction History

Regentatlantic Capital LLC

  • $3.34 Billion
  • Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Regentatlantic Capital LLC holds 12,956 shares of NVS stock, worth $1.48 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,956
Previous 15,850 18.26%
Holding current value
$1.48 Million
Previous $1.34 Million 26.49%
% of portfolio
0.03%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $215,921 - $252,530
-2,894 Reduced 18.26%
12,956 $985,000
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $102,663 - $119,531
-1,275 Reduced 7.45%
15,850 $1.34 Million
Q1 2022

May 02, 2022
SELL
$80.11 - $90.62 $114,877 - $129,949
-1,434 Reduced 7.73%
17,125 $1.5 Million
Q4 2021

Jan 27, 2022
SELL
$79.7 - $88.13 $46,226 - $51,115
-580 Reduced 3.03%
18,559 $1.62 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $123,487 - $143,661
-1,510 Reduced 7.31%
19,139 $1.57 Million
Q2 2021

Aug 12, 2021
SELL
$85.24 - $94.15 $209,519 - $231,420
-2,458 Reduced 10.64%
20,649 $1.88 Million
Q1 2021

Apr 29, 2021
BUY
$83.5 - $98.47 $1,419 - $1,673
17 Added 0.07%
23,107 $1.98 Million
Q4 2020

Feb 04, 2021
SELL
$78.07 - $94.43 $358,497 - $433,622
-4,592 Reduced 16.59%
23,090 $2.18 Million
Q3 2020

Oct 13, 2020
SELL
$82.14 - $91.0 $862,305 - $955,318
-10,498 Reduced 27.5%
27,682 $2.41 Million
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $221,505 - $249,340
-2,737 Reduced 6.69%
38,180 $3.34 Million
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $298,086 - $417,624
-4,218 Reduced 9.35%
40,917 $3.37 Million
Q4 2019

Feb 04, 2020
BUY
$84.35 - $95.37 $86,121 - $97,372
1,021 Added 2.31%
45,135 $4.27 Million
Q3 2019

Oct 22, 2019
SELL
$85.54 - $94.26 $13,857 - $15,270
-162 Reduced 0.37%
44,114 $3.83 Million
Q2 2019

Jul 23, 2019
BUY
$75.4 - $92.8 $1.36 Million - $1.68 Million
18,071 Added 68.96%
44,276 $4.04 Million
Q1 2019

May 03, 2019
BUY
$75.32 - $86.15 $148,079 - $169,370
1,966 Added 8.11%
26,205 $2.52 Million
Q4 2018

Jan 30, 2019
SELL
$73.66 - $82.02 $5,008 - $5,577
-68 Reduced 0.28%
24,239 $2.08 Million
Q3 2018

Oct 30, 2018
BUY
$66.94 - $77.43 $85,281 - $98,645
1,274 Added 5.53%
24,307 $2.09 Million
Q2 2018

Jul 31, 2018
SELL
$64.91 - $73.36 $87,758 - $99,182
-1,352 Reduced 5.54%
23,033 $1.74 Million
Q1 2018

Apr 23, 2018
SELL
$70.39 - $84.15 $71,657 - $85,664
-1,018 Reduced 4.01%
24,385 $1.97 Million
Q4 2017

Jan 23, 2018
SELL
$72.33 - $77.64 $8,824 - $9,472
-122 Reduced 0.48%
25,403 $2.13 Million
Q3 2017

Oct 25, 2017
BUY
$74.14 - $77.27 $1.89 Million - $1.97 Million
25,525
25,525 $2.19 Million

Others Institutions Holding NVS

# of Institutions
1,426
Shares Held
138M
Call Options Held
1.48M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $246B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Regentatlantic Capital LLC Portfolio

Follow Regentatlantic Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email